IDB Board Approves Capital Injection as Two Main Shareholders Bicker

The brainchild of co-chairman Eduardo Elsztain may reflect partner Moti Ben-Moshe’s decline at the conglomerate.

comments Print
IDB Development’s directors approved a 1.1-billion-shekel ($280 million) capital injection on Thursday, answering to pressure from creditors on one of Israel’s biggest conglomerates.